BusinessILiAD Biotechnologies BPZE1 Pertussis Vaccine Reaches Key Milestones Including Positive Phase 1b Clinical Study DataBy Nasdaq OMXJul 5, 2017, 1:00 PM UTC
BusinessPhase 1b Clinical Trial of BPZE1 Pertussis Vaccine Completes Enrollment of Randomized Study GroupsBy Nasdaq OMXFeb 19, 2016, 2:55 PM UTC
